logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Current Hematologic Malignancy Reports cover

Current Hematologic Malignancy Reports

IF3.3
Papers53
Citations1303
Journal Papers 53
Publication Date
delete
Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-11
delete0
deleteOAAI
deleteHamsa Murli; Sadia Alam; Evelyn Mesler; Aditi Shastri
deleteShare
deleteSave
Antigen Pressure, Clonal Evolution, and Lineage Plasticity in B-Cell Acute Lymphoblastic Leukemia: Resistance Biology in the Immunotherapy Era
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-07
delete0
PREAI
deleteJulio Alvarenga Thiebaud; Tamer Othman; Ibrahim Aldoss
deleteShare
deleteSave
Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-07
delete0
PREAI
deleteElisa Hofmeister; Ajay Major
deleteShare
deleteSave
Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-03
delete0
deleteOAAI
deleteSanam Loghavi; Robert P. Hasserjian
deleteShare
deleteSave
Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-07-13
delete0
deleteOAAI
deleteLiesl S. Eibschutz; Samuel Crow; Caroline Tatum; Daniel Reed; Michael Keng
deleteShare
deleteSave
Correction: Clonal Signatures of Telomere Biology Disorders
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-07-10
delete0
PREAI
deleteLuca Arcuri; Emma M. Groarke; Sharon A. Savage; Fernanda Gutierrez-Rodrigues
deleteShare
deleteSave
BRAF Alterations in Chronic Lymphocytic Leukemia: Genomic Landscape, Co-Mutation Patterns, and Clinical Relevance
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-05-01
delete0
deleteOAAI
deleteAbdulrahman Al-Abdulmalek; Eric Landry; Mohammed Abdulgayoom; Abdulrahman F. Al-Mashdali; Ayman Abdullah Dalol; Bassam Muthanna; Jean-Pierre Routy; Shehab F. Mohamed
deleteShare
deleteSave
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-25
delete0
PREAI
deleteZuhal Naderi; Teresa Sadras; Susan Branford; Naranie Shanmuganathan; Ilaria S. Pagani
deleteShare
deleteSave
Germline DDX41 Variants: Current Understanding and Future Directions
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-23
delete0
PREAI
deleteAldo A. Acosta-Medina; Abhishek A. Mangaonkar
deleteShare
deleteSave
Clonal Signatures of Telomere Biology Disorders
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-14
delete0
deleteOAAI
deleteLuca Arcuri; Emma M. Groarke; Sharon A. Savage; Fernanda Gutierrez-Rodrigues
deleteShare
deleteSave
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-03-07
delete0
deleteOAAI
deleteColette Hanna; Joe Rizkallah; Nicole Charbel; Shereen Sakkal; Fadi G. Haddad
deleteShare
deleteSave
The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-03-06
delete0
deleteOAAI
deleteAngela G Fleischman
deleteShare
deleteSave
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-26
delete0
deleteOAAI
deleteSamon Benrashid; Jennifer A. Woyach
deleteShare
deleteSave
Inotuzumab Ozogamicin in Clinical Practice: an Overview of Efficacy, Safety, and Real-World Applications
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-24
delete0
deleteOAAI
deleteValerie Tran; Nandan Srinivasa; Caroline Tatum; Daniel Reed; Michael Keng
deleteShare
deleteSave
New Approaches for Measurable Residual Disease Assessment in Multiple Myeloma: Integrating NGS, Mass Spectrometry, and Next-Generation Flow Cytometry to Monitor Treatment Response
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-14
delete0
PREAI
deleteBhavesh Mohan Lal; Shaji K. Kumar
deleteShare
deleteSave
The Role and Impact of Non-driver Gene Mutations in Myelofibrosis
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-10
delete0
deleteOAAI
deleteValentina Boldrini; Paola Guglielmelli; Alessandro M. Vannucchi
deleteShare
deleteSave
Advances and Controversies in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Navigating First-Line Therapies
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-03
delete0
PREAI
deleteTalia Zahra; Nadia Bambace; Lyle Feinstein; Charbel El Chaer; Yara Kadi; Michael A. Lezcano; Yenlys Vega; Tiba Al-Sagheer; Firas El Chaer
deleteShare
deleteSave
Understanding Triple Negative Myeloproliferative Neoplasms and Identifying Molecular Drivers
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-01-15
delete0
PREAI
deleteValentina Boldrini; Giuseppe G. Loscocco; Paola Guglielmelli; Naseema Gangat; Alessandro M. Vannucchi; Ayalew Tefferi
deleteShare
deleteSave
Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Development
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2025-12-29
delete0
deleteOAAI
deleteKateryna Fedorov; Leo Y. Luo; Alexander G. Bick; Michael R. Savona
deleteShare
deleteSave
Targeting RUNX1 Germline Variants: Agents Under Investigation
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2025-12-16
delete0
deleteOAAI
deleteSaman Ghalamkari; Christopher N. Hahn; Amelia Lau; Hamish S. Scott; Claire C. Homan; Anna L. Brown
deleteShare
deleteSave